Home › Calculator › ACAD Dividend Calculator 2026
ACAD Dividend Calculator 2026
No dividendHealthcareAcadia Pharmaceuticals Inc. · NASDAQ
Price: $20.17 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
ACAD is not a dividend-focused stock
ACAD pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
ACAD Dividend Yield
Acadia Pharmaceuticals Inc. (ACAD) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ACAD pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Acadia Pharmaceuticals Inc. (ACAD) — Dividend Analysis 2026
Acadia Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders. The company's marketed product, NUPLAZID (pimavanserin), is prescribed for the management of hallucinations and delusions associated with Parkinson's disease psychosis. Beyond its commercialized offering, ACADIA maintains a robust development pipeline, featuring several promising candidates: Pimavanserin: This compound is currently undergoing Phase 3 clinical trials for additional indications, specifically for Alzheimer's disease psychosis and the negative symptoms of schizophrenia. Trofinetide: A novel synthetic compound, Trofinetide is also in Phase 3 development, aimed at treating Rett syndrome. ACP-044: This orally administered, first-in-class non-opioid analgesic is progressing through Phase 2 studies for both acute and chronic pain. ACP-319: Identified as a positive allosteric modulator of the muscarinic receptor, ACP-319 is in Phase 1 development, exploring its potential for schizophrenia and improving cognition in Alzheimer's patients. Established in 1993, ACADIA Pharmaceuticals Inc. is headquartered in San Diego, California.
ACAD Dividend & DRIP — Frequently Asked Questions
Does ACAD pay a dividend?
No. Acadia Pharmaceuticals Inc. (ACAD) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of ACAD?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does ACAD have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. ACAD has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to ACAD
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ACAD DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ACAD position with:
🌍 ACAD Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ACAD.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ACAD Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ACAD Dividend Payment Schedule
ACAD pays quarterly — 4 times per year. Ex-div: —.
📊 ACAD vs Healthcare Benchmarks
How ACAD compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ACAD sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ACAD Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-08-06 | 14,292 | $17.84 | $255.0K | ||
| Sale | 2026-08-06 | 5,000 | $29.00 | $145.0K | ||
| M-Exempt | 2026-08-05 | 5,849 | $17.84 | $104.3K | ||
| M-Exempt | 2026-08-05 | 5,849 | $17.84 | $104.3K | ||
| Sale | 2026-08-06 | 9,292 | $29.34 | $272.6K | ||
| Sale | 2026-08-05 | 5,849 | $29.00 | $169.6K | ||
| M-Exempt | 2026-08-06 | 14,292 | $17.84 | $255.0K | ||
| M-Exempt | 2026-07-29 | 32,272 | — | — | ||
| M-Exempt | 2026-07-29 | 32,272 | — | — | ||
| Sale | 2026-07-30 | 16,508 | $26.13 | $431.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ACAD with peers: ACAD vs ADMA · ACAD vs BLTE · ACAD vs CRNX
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ACAD dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Acadia Pharmaceuticals Inc. (ACAD) is currently trading at $20.17, 35% below its 52-week high. It does not currently pay a regular dividend.
Does ACAD Pay a Dividend? Acadia Pharmaceuticals Inc. Dividend Status
Acadia Pharmaceuticals Inc. (ACAD) is a healthcare stock trading at $20.17. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ACAD News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your ACAD DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.